HOB Biotech Group Corp.,Ltd (688656.SS)
CNY 102.72
(-1.37%)
CNY 102.72
(-1.37%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 244.99 Million CNY | 21.13% |
| 2022 | 202.25 Million CNY | -7.71% |
| 2021 | 219.16 Million CNY | 50.67% |
| 2020 | 145.45 Million CNY | -17.54% |
| 2019 | 176.39 Million CNY | 23.97% |
| 2018 | 142.28 Million CNY | 39.48% |
| 2017 | 102.01 Million CNY | 39.26% |
| 2016 | 73.25 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | 66.21 Million CNY | -6.91% |
| 2024 Q2 | 71.12 Million CNY | 33.85% |
| 2024 Q1 | 53.14 Million CNY | -6.08% |
| 2023 Q3 | 72.72 Million CNY | 4.87% |
| 2023 FY | 244.99 Million CNY | 21.13% |
| 2023 Q4 | 56.58 Million CNY | -22.2% |
| 2023 Q2 | 69.34 Million CNY | 49.66% |
| 2023 Q1 | 46.33 Million CNY | 21.97% |
| 2022 FY | 202.25 Million CNY | -7.71% |
| 2022 Q3 | 68.07 Million CNY | 40.99% |
| 2022 Q2 | 48.28 Million CNY | 0.78% |
| 2022 Q1 | 47.9 Million CNY | -9.82% |
| 2022 Q4 | 37.99 Million CNY | -44.19% |
| 2021 FY | 219.16 Million CNY | 50.67% |
| 2021 Q4 | 53.12 Million CNY | -16.08% |
| 2021 Q3 | 63.3 Million CNY | 1.49% |
| 2021 Q2 | 62.37 Million CNY | 54.57% |
| 2021 Q1 | 40.35 Million CNY | -20.49% |
| 2020 FY | 145.45 Million CNY | -17.54% |
| 2020 Q4 | 50.75 Million CNY | 10.85% |
| 2020 Q3 | 45.78 Million CNY | 60.4% |
| 2020 Q1 | 12.58 Million CNY | -70.31% |
| 2020 Q2 | 28.54 Million CNY | 126.75% |
| 2019 FY | 176.39 Million CNY | 23.97% |
| 2019 Q4 | 42.4 Million CNY | -9.72% |
| 2019 Q3 | 46.96 Million CNY | -36.04% |
| 2019 Q2 | 73.43 Million CNY | 39.99% |
| 2019 Q1 | 52.46 Million CNY | 0.0% |
| 2018 FY | 142.28 Million CNY | 39.48% |
| 2017 FY | 102.01 Million CNY | 39.26% |
| 2016 FY | 73.25 Million CNY | 0.0% |